AR
Advisory Research Portfolio holdings
AUM
$651M
This Quarter Return
+9.44%
1 Year Return
+25.02%
3 Year Return
+143.09%
5 Year Return
+422.22%
10 Year Return
+498.78%
AUM
$1.25B
AUM Growth
+$1.25B
(-1.8%)
Cap. Flow
-$49.3M
Cap. Flow
% of AUM
-3.95%
Top 10 Holdings %
Top 10 Hldgs %
36.19%
Holding
463
New
112
Increased
98
Reduced
115
Closed
63
Top Buys
| 1 |
Ovintiv
OVV
|
$34.2M |
| 2 |
Antero Resources
AR
|
$19.6M |
| 3 |
Fox Class A
FOXA
|
$8.38M |
| 4 |
Home Depot
HD
|
$7.86M |
| 5 |
Danaos Corp
DAC
|
$6.23M |
Top Sells
| 1 |
EQT Corp
EQT
|
$59.4M |
| 2 |
Coterra Energy
CTRA
|
$23.5M |
| 3 |
Devon Energy
DVN
|
$21.5M |
| 4 |
ING
ING
|
$19M |
| 5 |
Occidental Petroleum
OXY
|
$11.8M |
Sector Composition
| 1 | Energy | 33.98% |
| 2 | Technology | 11.4% |
| 3 | Healthcare | 10.88% |
| 4 | Industrials | 10.02% |
| 5 | Consumer Discretionary | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Medtronic
MDT
$118B
| $1.61M | 0.13% |
14,531
-3,376
| -19% | -$375K |
|
127
Portillo's
PTLO
$488M
| $1.59M | 0.13% |
64,691
+28,403
| +78% | +$698K |
|
128
CDW
CDW
$21.4B
| $1.59M | 0.13% |
8,874
-1,873
| -17% | -$335K |
|
129
Hercules Capital
HTGC
$3.51B
| $1.58M | 0.13% |
87,263
-7,831
| -8% | -$142K |
|
130
Vicor
VICR
$2.27B
| $1.57M | 0.13% |
22,201
-26,158
| -54% | -$1.85M |
|
131
Warby Parker
WRBY
$3.08B
| $1.56M | 0.13% |
46,185
+32,971
| +250% | +$1.12M |
|
|
AGTI
132
DELISTED
Agiliti, Inc.
AGTI
| $1.55M | 0.12% |
73,469
-71,440
| -49% | -$1.51M |
|
133
Custom Truck One Source
CTOS
$1.37B
| $1.53M | 0.12% |
182,727
+80,726
| +79% | +$677K |
|
|
CERE
134
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.53M | 0.12% |
+43,591
| New | +$1.53M |
|
135
American Express
AXP
$225B
| $1.52M | 0.12% |
8,120
-3,337
| -29% | -$624K |
|
136
Lam Research
LRCX
$124B
| $1.51M | 0.12% |
28,000
-280
| -1% | -$15.1K |
|
|
HEES
137
DELISTED
H&E Equipment Services
HEES
| $1.5M | 0.12% |
34,443
-2,090
| -6% | -$91K |
|
|
INTE
138
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
| $1.5M | 0.12% |
151,180
| – | – |
|
139
Cantaloupe
CTLP
$795M
| $1.49M | 0.12% |
220,000
| – | – |
|
140
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $1.48M | 0.12% |
30,809
| – | – |
|
141
JPMorgan Chase
JPM
$824B
| $1.48M | 0.12% |
10,849
-2,828
| -21% | -$386K |
|
142
Cleveland-Cliffs
CLF
$5.18B
| $1.48M | 0.12% |
+45,800
| New | +$1.48M |
|
143
Luxfer Holdings
LXFR
$354M
| $1.47M | 0.12% |
87,715
+26,375
| +43% | +$443K |
|
144
Abbott
ABT
$230B
| $1.47M | 0.12% |
12,415
-2,800
| -18% | -$331K |
|
145
Cytokinetics
CYTK
$5.98B
| $1.46M | 0.12% |
39,732
-3,086
| -7% | -$114K |
|
146
AEON Biopharma
AEON
$9.43M
| $1.46M | 0.12% |
2,066
| – | – |
|
147
FS KKR Capital
FSK
$5.06B
| $1.45M | 0.12% |
63,586
-4,195
| -6% | -$95.7K |
|
148
Illinois Tool Works
ITW
$76.2B
| $1.45M | 0.12% |
6,917
-11
| -0.2% | -$2.3K |
|
149
Sixth Street Specialty
TSLX
$2.32B
| $1.44M | 0.12% |
61,888
-3,428
| -5% | -$79.8K |
|
|
PCN
150
PIMCO Corporate & Income Strategy Fund
PCN
$837M
| $1.42M | 0.11% |
90,000
| – | – |
|